Predicting the risk of relapse in opioid use disorder using digital tools
Contextualized daily prediction of lapse risk in opioid use disorder by digital phenotyping
This study is testing a new mobile app designed to help people recovering from opioid use disorder by predicting their daily risk of relapse, so they can get personalized support and stay on track with their recovery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10642766 on NIH RePORTER |
What this research studies
This research aims to develop a mobile app that predicts the daily risk of relapse for individuals recovering from opioid use disorder. By utilizing digital phenotyping, the app will analyze various factors that influence a person's likelihood of using opioids again. Participants will be monitored over a year, allowing the app to provide personalized feedback and support based on their unique recovery journey. The goal is to enhance the effectiveness of existing treatment methods by helping individuals recognize and respond to their relapse risks in real-time.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are actively pursuing abstinence.
Not a fit: Patients who are not seeking recovery from opioid use disorder or are not diagnosed with the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the chances of sustained recovery for individuals with opioid use disorder.
How similar studies have performed: Previous research has shown promise in using digital tools for monitoring and supporting recovery in substance use disorders, indicating a potential for success in this approach.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Curtin, John J. — University of Wisconsin-Madison
- Study coordinator: Curtin, John J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.